Cubist Systematic Strategies’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-91,330
| Closed | -$417K | – | 2369 |
|
|
2025
Q1 | $417K | Sell |
91,330
-26,270
| -22% | -$120K | ﹤0.01% | 1055 |
|
|
2024
Q4 | $663K | Sell |
117,600
-561,025
| -83% | -$3.16M | ﹤0.01% | 922 |
|
|
2024
Q3 | $3.28M | Buy |
678,625
+282,926
| +72% | +$1.37M | 0.02% | 497 |
|
|
2024
Q2 | $1.93M | Buy |
395,699
+281,173
| +246% | +$1.37M | 0.01% | 591 |
|
|
2024
Q1 | $1.52M | Sell |
114,526
-29,407
| -20% | -$391K | 0.01% | 983 |
|
|
2023
Q4 | $2.01M | Buy |
143,933
+27,235
| +23% | +$380K | 0.01% | 819 |
|
|
2023
Q3 | $1.55M | Buy |
116,698
+78,141
| +203% | +$1.04M | 0.01% | 879 |
|
|
2023
Q2 | $723K | Sell |
38,557
-129,569
| -77% | -$2.43M | ﹤0.01% | 1281 |
|
|
2023
Q1 | $2.42M | Buy |
168,126
+111,004
| +194% | +$1.6M | 0.01% | 1014 |
|
|
2022
Q4 | $1.11M | Buy |
57,122
+36,936
| +183% | +$715K | 0.01% | 1684 |
|
|
2022
Q3 | $693K | Sell |
20,186
-105,943
| -84% | -$3.64M | ﹤0.01% | 2299 |
|
|
2022
Q2 | $1.93M | Buy |
126,129
+101,663
| +416% | +$1.55M | 0.01% | 1610 |
|
|
2022
Q1 | $558K | Buy |
+24,466
| New | +$558K | ﹤0.01% | 2447 |
|
|
2021
Q4 | – | Sell |
-6,406
| Closed | -$301K | – | 3652 |
|
|
2021
Q3 | $301K | Buy |
6,406
+6,055
| +1,725% | +$285K | ﹤0.01% | 2351 |
|
|
2021
Q2 | $21K | Buy |
+351
| New | +$21K | ﹤0.01% | 2845 |
|